Literature DB >> 24026395

Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study.

Seamus P Whelton, Probal Roy, Brad C Astor, Lin Zhang, Ron C Hoogeveen, Christie M Ballantyne, Josef Coresh.   

Abstract

The relationship between cholesterol and coronary heart disease (CHD) is attenuated at older age. We analyzed cholesterol level as a predictor of CHD in 8,947 participants from the Atherosclerosis Risk in Communities (ARIC) Study, a large multicenter cohort study that enrolled participants in 1987-1989 at 4 field centers in Washington County, Maryland; Forsyth County, North Carolina; Jackson, Mississippi; and Minneapolis, Minnesota. Participants in the present analysis had no history of CHD and were stratified by age (<65 or ≥65 years) and high-sensitivity C-reactive protein (hs-CRP) level (<2 or ≥2 mg/L). Visit 4 (1996-1997) was the baseline for this analysis, with follow-up through 2008. Cholesterol level was significantly associated with CHD among younger participants, and cholesterol level was similarly predictive of CHD among older participants with an hs-CRP level of <2 mg/L. In contrast, among older participants with an hs-CRP level of 2 mg/L or higher, the association of CHD with total cholesterol level was borderline significant (hazard ratio = 1.14, 95% confidence interval: 1.00, 1.29), and the association of CHD with low-density lipoprotein cholesterol level was nonsignificant (hazard ratio = 1.10; 95% confidence interval: 0.96, 1.26). Among older persons with an elevated hs-CRP level, cholesterol level was significantly less predictive of CHD (P < 0.05), whereas for those with an hs-CRP level of <2 mg/L, there was no significant difference compared with younger participants. In conclusion, we found that among the young-old, the association of cholesterol level with CHD was strong when hs-CRP level was not elevated and weak when hs-CRP level was elevated. Therefore, hs-CRP level could be useful for stratifying the young-old to assess the strength of cholesterol level in CHD risk prediction.

Entities:  

Keywords:  C-reactive protein; elderly persons; serum cholesterol

Mesh:

Substances:

Year:  2013        PMID: 24026395      PMCID: PMC3783092          DOI: 10.1093/aje/kwt086

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  38 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study (ARIC). The ARIC Study Group.

Authors: 
Journal:  J Neuroimaging       Date:  1991-05       Impact factor: 2.486

3.  Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study.

Authors:  P Zimetbaum; W H Frishman; W L Ooi; M P Derman; M Aronson; L I Gidez; H A Eder
Journal:  Arterioscler Thromb       Date:  1992-04

4.  Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data.

Authors:  R A Kronmal; K C Cain; Z Ye; G S Omenn
Journal:  Arch Intern Med       Date:  1993-05-10

5.  Report of the Conference on Low Blood Cholesterol: Mortality Associations.

Authors:  D Jacobs; H Blackburn; M Higgins; D Reed; H Iso; G McMillan; J Neaton; J Nelson; J Potter; B Rifkind
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

6.  C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.

Authors:  Paul M Ridker; Julie E Buring; Nancy R Cook; Nader Rifai
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

7.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

Authors:  Rory Collins; Jane Armitage; Sarah Parish; Peter Sleigh; Richard Peto
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

8.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

Authors:  J Stamler; D Wentworth; J D Neaton
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

9.  Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.

Authors:  Yongmei Liu; Josef Coresh; Joseph A Eustace; J Craig Longenecker; Bernard Jaar; Nancy E Fink; Russell P Tracy; Neil R Powe; Michael J Klag
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  15 in total

1.  Protection of salvianolate against atherosclerosis via regulating the inflammation in rats.

Authors:  Chun Meng; Xiao-Qing Zhuo; Guo-Hong Xu; Jian-Li Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

2.  Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults.

Authors:  Anum Saeed; Vijay Nambi; Wensheng Sun; Salim S Virani; George E Taffet; Anita Deswal; Elizabeth Selvin; Kunihiro Matsushita; Lynne E Wagenknecht; Ron Hoogeveen; Josef Coresh; James A de Lemos; Christie M Ballantyne
Journal:  J Am Coll Cardiol       Date:  2018-03-10       Impact factor: 24.094

3.  sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Mahmoud Al Rifai; Andrea L C Schneider; Alvaro Alonso; Nisa Maruthur; Christina M Parrinello; Brad C Astor; Ron C Hoogeveen; Elsayed Z Soliman; Lin Y Chen; Christie M Ballantyne; Marc K Halushka; Elizabeth Selvin
Journal:  J Diabetes Complications       Date:  2014-11-25       Impact factor: 2.852

Review 4.  Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives.

Authors:  Daniel E Forman; James A de Lemos; Leslee J Shaw; David B Reuben; Radmila Lyubarova; Eric D Peterson; John A Spertus; Susan Zieman; Marcel E Salive; Michael W Rich
Journal:  J Am Coll Cardiol       Date:  2020-09-29       Impact factor: 24.094

5.  Perceived Discrimination and Trajectories of C-Reactive Protein: The Jackson Heart Study.

Authors:  Kendra D Sims; Mario Sims; LáShauntá M Glover; Ellen Smit; Michelle C Odden
Journal:  Am J Prev Med       Date:  2019-12-10       Impact factor: 5.043

6.  Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Oluwaseun E Fashanu; Faye L Norby; David Aguilar; Christie M Ballantyne; Ron C Hoogeveen; Lin Y Chen; Elsayed Z Soliman; Alvaro Alonso; Aaron R Folsom
Journal:  Am Heart J       Date:  2017-07-08       Impact factor: 4.749

7.  Attention to detail in the selection of words in epidemiologic research reports.

Authors:  Philip Greenland; Mark Pepys
Journal:  Am J Epidemiol       Date:  2014-02-20       Impact factor: 4.897

8.  Synergistic and Non-synergistic Associations for Cigarette Smoking and Non-tobacco Risk Factors for Cardiovascular Disease Incidence in the Atherosclerosis Risk In Communities (ARIC) Study.

Authors:  Jay H Lubin; David Couper; Pamela L Lutsey; Hiroshi Yatsuya
Journal:  Nicotine Tob Res       Date:  2017-07-01       Impact factor: 4.244

9.  Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES).

Authors:  Mark G O'Doherty; Torben Jørgensen; Anders Borglykke; Hermann Brenner; Ben Schöttker; Tom Wilsgaard; Galatios Siganos; Maryam Kavousi; Maria Hughes; Aysel Müezzinler; Bernd Holleczek; Oscar H Franco; Albert Hofman; Paolo Boffetta; Antonia Trichopoulou; Frank Kee
Journal:  Eur J Epidemiol       Date:  2014-11-25       Impact factor: 8.082

10.  Cardiovascular risk and aging: the need for a more comprehensive understanding.

Authors:  Ljiljana Trtica Majnarić; Zvonimir Bosnić; Tomislav Kurevija; Thomas Wittlinger
Journal:  J Geriatr Cardiol       Date:  2021-06-28       Impact factor: 3.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.